openPR Logo
Press release

Carcinoembryonic Antigen (CEA) Market to hit $2.7bn by 2023

06-20-2017 10:59 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Global Market Insights, Inc.

Global Market Insights, Inc.

Carcinoembryonic Antigen (CEA) Market size is driven by increasing incidence rate for cancer disease especially colorectal cancer is one of the important factor contributing to the growth. Global Carcinoembryonic Antigen Market is set to register profitable growth in the near future and surpass USD 2.8 billion by 2023.

This growth is attributed to factors including consistent technology advancements, development of novel biomarkers and growing prevalence of cancer. Global Market Insights, Inc. announces the addition of a new research report on Carcinoembryonic Antigen (CEA) market to their offering.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/427

The report gives you a basic overview of the CEA market with market definition, applications, segmentation, and value chain analysis. The report covers competitive landscape with the leading company profiles and recent events in the industry. Equipped with all vital information including current scenario, forecasts, and future predictions, it offers insights to foresee challenges and opportunities that will aid in making informed decisions.

Growing demand for minimally invasive diagnostics procedures is projected to contribute a significant part in shaping market growth. Increasing geriatric population is another key factor to intensify the Carcinoembryonic Antigen market growth. The development of novel combination biomarkers and initiatives by the government concerning improved diagnostic rates are likely to open growth avenues for CEA market. The advent of various tumor markers, which can be used along with CEA to monitor or diagnose colorectal cancer is predicted to influence the market growth positively.

To access sample pages or view this report titled, “Carcinoembryonic Antigen (CEA) Market Size By Application (Colorectal, Pancreatic, Ovarian, Breast, Thyroid Cancer], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, Spain, Japan, China, India, Mexico, Brazil, South Africa), Application Potential, Competitive Market Share & Forecast, 2016 – 2023” in detail along with the table of contents, please click on the link below:

https://www.gminsights.com/industry-analysis/carcinoembryonic-antigen-cea-market

North America, hinged on the U.S. Carcinoembryonic Antigen market size, is predicted to lead the segment with estimations of USD 800 million in 2016. Growing awareness about detecting cancer at an early stage and improved health care services for cancer therapeutics are anticipated to propel growth. Asia-Pacific region driven by India and China is targeted to foresee growing prevalence of cancer owing to changes in lifestyle and aging population in the area. The growth is mainly attributed to improved treatment facilities and high disposable income. The Asia-Pacific market share can surpass USD 380 million in the near future.

Colorectal cancer tops the application segment and is expected to foresee growth over the forecast period. Breast cancer segment is likely to be the most lucrative with estimations of over USD 460 million at over 7% CAGR during the projected time frame.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/427

The key players in global carcinoembryonic antigen market include Quest Diagnostics, Roche Diagnostics, GenWay Biotech, Inc. and Abbott Diagnostics

Focus on early detection methods and product innovation owing to rising demand for minimally invasive procedures is a key strategy adopted by the key participants in the market.

Browse Related Reports:

Bioreactor Market Size By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, Others), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, Others), By Technology (Wave-Induced Motion SUB, Stirred SUB, Single Use Bubble Column, Other SUB), By End-Use ( R&D organizations, Biopharma Manufacturers, CMOs) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Spain, Italy, France, Netherland, Denmark, China, Japan, India, South Korea, Australia, Singapore, Brazil, Mexico, UAE, South Africa), Application Development, Price Trend, Competitive Landscape & Forecast, 2017 – 2024

https://www.gminsights.com/industry-analysis/bioreactor-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carcinoembryonic Antigen (CEA) Market to hit $2.7bn by 2023 here

News-ID: 586974 • Views:

More Releases from Global Market Insights, Inc.

Hepatitis B Vaccine Market Set to Surpass $12 Billion by 2034
Hepatitis B Vaccine Market Set to Surpass $12 Billion by 2034
The global hepatitis B vaccine market is poised for significant expansion over the next decade, fueled by rising liver disease cases, expanded immunization coverage, and advancements in vaccine development. Valued at USD 6.7 billion in 2024, the market is projected to reach USD 7.3 billion in 2025 and surge to USD 12 billion by 2034, reflecting a healthy compound annual growth rate (CAGR) of 5.7%. A major driver behind this growth
Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health. This in turn has led to a surge in demand for various functional foods
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock. According to Global Market Insights Inc estimates
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key players Eaton, Schneider, Siemens, Hitachi, Powell, Hubbell
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091 Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group

All 5 Releases


More Releases for Carcinoembryonic

Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: A …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The size of the carcinoembryonic antigen market has experienced swift growth in the previous years. There will be an increase from $1.22 billion in 2024 to $1.38 billion in 2025, exhibiting a compound annual growth
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth Dri …
What combination of drivers is leading to accelerated growth in the carcinoembryonic antigen market? The surge in cancer cases is anticipated to fuel the expansion of the carcinoembryonic antigen market in the future. Cancer is an ailment identified by unregulated proliferation and dissemination of irregular cells. The prevalence of cancer is increasing owing to aspects such as lifestyle alternatives, environmental contamination, genetic susceptibility, and a growing elderly population. Carcinoembryonic antigen (CEA)
Carcinoembryonic Antigen Market Analysis, Growth Forecast 2024-2033
The new report published by The Business Research Company, titled ""Carcinoembryonic Antigen Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the carcinoembryonic antigen market size has grown rapidly in recent years. It will grow from $1.07 billion in
Carcinoembryonic Antigen (CEA) Market Size, Share | Industry Report 2026
The global Carcinoembryonic Antigen (CEA) Market was valued at $5.3 Billion in 2018 and is forecast to grow at a modest 6.1 % CAGR between 2018 and 2026, culminating in 2026 global sales of $ 9.2 Billion. Carcinoembryonic AntigenTest is a blood test which identifies the diagnose and manage certain cancer disease like rectum and large intestine. Basically, it is used to check how well treatment is working in certain
Carcinoembryonic Antigen Industry Continues Growth |Quest Diagnostics, GenWay Bi …
The Report “Carcinoembryonic Antigen Market Size By Application, By Gender (Male, Female), By End-user, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024” Carcinoembryonic Antigen Market will reach USD 3.0 billion by 2024 UK carcinoembryonic antigen market is projected to grow at significant CAGR of 6.7% over the forecast time period. Rapidly increasing geriatric population, technological advancements, and growing healthcare expenditure in the
Upcoming Trends in Carcinoembryonic Antigen Market till 2016 – 2023
Carcinoembryonic antigens are glycoproteins that play a major role in cell adhesion. Carcinoembryonic antigen is present at very low concentration in healthy adults. Normal carcinoembryonic antigen level in healthy adult is in range between 2.5-5.0 µg/L. Level up may increase due to benign disease or smoking. However, its concentration in serum rise very high in some types of cancer. Hence, carcinoembryonic antigen used as a marker and assist in monitoring